CASI
CASI Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CASI Filings
Filing Date
Form Description
Form Type
2025-11-26
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-26 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-14 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-26
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-09-26 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-09-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-08-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-08-29 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-08-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-08-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
